Which has better earnings & valuation, GLAS or ALMS?

Glass House Brands has higher revenue and earnings than Alumis. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Glass House Brands $176.02M 4.82 N/A N/A N/A Alumis $8.40M 437.09 -$243.32M -$1.98 N/A

Does the media favor GLAS or ALMS?

In the previous week, Alumis had 2 more articles in the media than Glass House Brands. MarketBeat recorded 4 mentions for Alumis and 2 mentions for Glass House Brands. Alumis' average media sentiment score of 1.08 beat Glass House Brands' score of 0.00 indicating that Alumis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Glass House Brands 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alumis 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, ADPT or GLAS?

Glass House Brands has lower revenue, but higher earnings than Adaptive Biotechnologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Adaptive Biotechnologies $276.98M 12.65 -$59.50M -$0.33 N/A Glass House Brands $176.02M 4.82 N/A N/A N/A

Does the media refer more to ADPT or GLAS?

In the previous week, Adaptive Biotechnologies had 6 more articles in the media than Glass House Brands. MarketBeat recorded 8 mentions for Adaptive Biotechnologies and 2 mentions for Glass House Brands. Adaptive Biotechnologies' average media sentiment score of 1.07 beat Glass House Brands' score of 0.00 indicating that Adaptive Biotechnologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adaptive Biotechnologies 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Glass House Brands 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings & valuation, GLAS or ARQT?

Glass House Brands has higher earnings, but lower revenue than Arcutis Biotherapeutics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Glass House Brands $176.02M 4.82 N/A N/A N/A Arcutis Biotherapeutics $415.62M 8.40 -$16.14M -$0.03 N/A

Does the media refer more to GLAS or ARQT?

In the previous week, Arcutis Biotherapeutics had 3 more articles in the media than Glass House Brands. MarketBeat recorded 5 mentions for Arcutis Biotherapeutics and 2 mentions for Glass House Brands. Arcutis Biotherapeutics' average media sentiment score of 0.62 beat Glass House Brands' score of 0.00 indicating that Arcutis Biotherapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Glass House Brands 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Arcutis Biotherapeutics 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer GLAS or GMTX?

Glass House Brands currently has a consensus price target of $17.00, indicating a potential upside of 60.92%. Given Glass House Brands' stronger consensus rating and higher possible upside, analysts plainly believe Glass House Brands is more favorable than Gemini Therapeutics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Glass House Brands 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67 Gemini Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings & valuation, GLAS or GMTX?

Glass House Brands has higher revenue and earnings than Gemini Therapeutics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Glass House Brands $176.02M 4.82 N/A N/A N/A Gemini Therapeutics N/A N/A -$71.87M -$1.00 N/A

Is GLAS or GMTX more profitable?

Glass House Brands' return on equity of 0.00% beat Gemini Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Glass House Brands N/A N/A N/A Gemini Therapeutics N/A -38.78% -35.88%

Which has higher valuation & earnings, GLAS or IDYA?

Glass House Brands has higher earnings, but lower revenue than IDEAYA Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Glass House Brands $176.02M 4.82 N/A N/A N/A IDEAYA Biosciences $225.27M 13.78 -$113.70M -$1.60 N/A

Is GLAS or IDYA more profitable?

Glass House Brands' return on equity of 0.00% beat IDEAYA Biosciences' return on equity. Company Net Margins Return on Equity Return on Assets Glass House Brands N/A N/A N/A IDEAYA Biosciences N/A -14.24% -13.09%

Does the media favor GLAS or IDYA?

In the previous week, IDEAYA Biosciences had 4 more articles in the media than Glass House Brands. MarketBeat recorded 6 mentions for IDEAYA Biosciences and 2 mentions for Glass House Brands. IDEAYA Biosciences' average media sentiment score of 0.54 beat Glass House Brands' score of 0.00 indicating that IDEAYA Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Glass House Brands 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral IDEAYA Biosciences 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Glass House Brands (GLAS) Competitors

$10.56 -0.17 (-1.55%)

As of 02:00 PM Eastern

Compare

GLAS vs. ALMS, ADPT, ARQT, GMTX, and IDYA

Should you buy Glass House Brands stock or one of its competitors? MarketBeat compares Glass House Brands with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Glass House Brands include Alumis (ALMS), Adaptive Biotechnologies (ADPT), Arcutis Biotherapeutics (ARQT), Gemini Therapeutics (GMTX), and IDEAYA Biosciences (IDYA). These companies are all part of the "pharmaceutical products" industry.

How does Glass House Brands compare to Alumis?

Glass House Brands (NYSE:GLAS) and Alumis (NASDAQ:ALMS) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability.

Glass House Brands has a net margin of 0.00% compared to Alumis' net margin of -2,825.70%. Glass House Brands' return on equity of 0.00% beat Alumis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Glass House Brands	N/A	N/A	N/A
Alumis	-2,825.70%	-88.79%	-70.72%

Glass House Brands has higher revenue and earnings than Alumis.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Glass House Brands	$176.02M	4.82	N/A	N/A	N/A
Alumis	$8.40M	437.09	-$243.32M	-$1.98	N/A

Glass House Brands presently has a consensus target price of $17.00, suggesting a potential upside of 60.92%. Alumis has a consensus target price of $40.30, suggesting a potential upside of 39.91%. Given Glass House Brands' higher probable upside, analysts plainly believe Glass House Brands is more favorable than Alumis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glass House Brands	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Alumis	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.83

In the previous week, Alumis had 2 more articles in the media than Glass House Brands. MarketBeat recorded 4 mentions for Alumis and 2 mentions for Glass House Brands. Alumis' average media sentiment score of 1.08 beat Glass House Brands' score of 0.00 indicating that Alumis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Glass House Brands	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alumis	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Glass House Brands and Alumis tied by winning 5 of the 10 factors compared between the two stocks.

How does Glass House Brands compare to Adaptive Biotechnologies?

Adaptive Biotechnologies (NASDAQ:ADPT) and Glass House Brands (NYSE:GLAS) are both pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

In the previous week, Adaptive Biotechnologies had 6 more articles in the media than Glass House Brands. MarketBeat recorded 8 mentions for Adaptive Biotechnologies and 2 mentions for Glass House Brands. Adaptive Biotechnologies' average media sentiment score of 1.07 beat Glass House Brands' score of 0.00 indicating that Adaptive Biotechnologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Adaptive Biotechnologies	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Glass House Brands	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Adaptive Biotechnologies presently has a consensus price target of $20.83, indicating a potential downside of 4.87%. Glass House Brands has a consensus price target of $17.00, indicating a potential upside of 60.92%. Given Glass House Brands' stronger consensus rating and higher probable upside, analysts clearly believe Glass House Brands is more favorable than Adaptive Biotechnologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adaptive Biotechnologies	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Glass House Brands	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Glass House Brands has a net margin of 0.00% compared to Adaptive Biotechnologies' net margin of -16.82%. Glass House Brands' return on equity of 0.00% beat Adaptive Biotechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adaptive Biotechnologies	-16.82%	-40.06%	-16.64%
Glass House Brands	N/A	N/A	N/A

99.2% of Adaptive Biotechnologies shares are owned by institutional investors. 5.7% of Adaptive Biotechnologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Glass House Brands has lower revenue, but higher earnings than Adaptive Biotechnologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adaptive Biotechnologies	$276.98M	12.65	-$59.50M	-$0.33	N/A
Glass House Brands	$176.02M	4.82	N/A	N/A	N/A

Summary

Adaptive Biotechnologies beats Glass House Brands on 7 of the 13 factors compared between the two stocks.

How does Glass House Brands compare to Arcutis Biotherapeutics?

Glass House Brands (NYSE:GLAS) and Arcutis Biotherapeutics (NASDAQ:ARQT) are both pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

Glass House Brands has a net margin of 0.00% compared to Arcutis Biotherapeutics' net margin of -0.57%. Glass House Brands' return on equity of 0.00% beat Arcutis Biotherapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Glass House Brands	N/A	N/A	N/A
Arcutis Biotherapeutics	-0.57%	-1.41%	-0.59%

In the previous week, Arcutis Biotherapeutics had 3 more articles in the media than Glass House Brands. MarketBeat recorded 5 mentions for Arcutis Biotherapeutics and 2 mentions for Glass House Brands. Arcutis Biotherapeutics' average media sentiment score of 0.62 beat Glass House Brands' score of 0.00 indicating that Arcutis Biotherapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Glass House Brands	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Arcutis Biotherapeutics	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Glass House Brands has higher earnings, but lower revenue than Arcutis Biotherapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Glass House Brands	$176.02M	4.82	N/A	N/A	N/A
Arcutis Biotherapeutics	$415.62M	8.40	-$16.14M	-$0.03	N/A

Glass House Brands presently has a consensus target price of $17.00, suggesting a potential upside of 60.92%. Arcutis Biotherapeutics has a consensus target price of $34.00, suggesting a potential upside of 21.76%. Given Glass House Brands' stronger consensus rating and higher possible upside, equities research analysts clearly believe Glass House Brands is more favorable than Arcutis Biotherapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glass House Brands	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Arcutis Biotherapeutics	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Glass House Brands beats Arcutis Biotherapeutics on 6 of the 11 factors compared between the two stocks.

How does Glass House Brands compare to Gemini Therapeutics?

Glass House Brands (NYSE:GLAS) and Gemini Therapeutics (NASDAQ:GMTX) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

75.4% of Gemini Therapeutics shares are held by institutional investors. 12.9% of Gemini Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Glass House Brands currently has a consensus price target of $17.00, indicating a potential upside of 60.92%. Given Glass House Brands' stronger consensus rating and higher possible upside, analysts plainly believe Glass House Brands is more favorable than Gemini Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glass House Brands	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Gemini Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Glass House Brands' return on equity of 0.00% beat Gemini Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Glass House Brands	N/A	N/A	N/A
Gemini Therapeutics	N/A	-38.78%	-35.88%

Glass House Brands has higher revenue and earnings than Gemini Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Glass House Brands	$176.02M	4.82	N/A	N/A	N/A
Gemini Therapeutics	N/A	N/A	-$71.87M	-$1.00	N/A

In the previous week, Glass House Brands had 2 more articles in the media than Gemini Therapeutics. MarketBeat recorded 2 mentions for Glass House Brands and 0 mentions for Gemini Therapeutics. Glass House Brands' average media sentiment score of 0.00 equaled Gemini Therapeutics'average media sentiment score.

Company	Overall Sentiment
Glass House Brands	Neutral
Gemini Therapeutics	Neutral

Summary

Glass House Brands beats Gemini Therapeutics on 8 of the 10 factors compared between the two stocks.

How does Glass House Brands compare to IDEAYA Biosciences?

Glass House Brands (NYSE:GLAS) and IDEAYA Biosciences (NASDAQ:IDYA) are both pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Glass House Brands presently has a consensus target price of $17.00, indicating a potential upside of 60.92%. IDEAYA Biosciences has a consensus target price of $50.25, indicating a potential upside of 42.23%. Given Glass House Brands' higher possible upside, equities analysts plainly believe Glass House Brands is more favorable than IDEAYA Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glass House Brands	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
IDEAYA Biosciences	1 Sell rating(s)	1 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.81

Glass House Brands has higher earnings, but lower revenue than IDEAYA Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Glass House Brands	$176.02M	4.82	N/A	N/A	N/A
IDEAYA Biosciences	$225.27M	13.78	-$113.70M	-$1.60	N/A

98.3% of IDEAYA Biosciences shares are owned by institutional investors. 4.7% of IDEAYA Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Glass House Brands' return on equity of 0.00% beat IDEAYA Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Glass House Brands	N/A	N/A	N/A
IDEAYA Biosciences	N/A	-14.24%	-13.09%

In the previous week, IDEAYA Biosciences had 4 more articles in the media than Glass House Brands. MarketBeat recorded 6 mentions for IDEAYA Biosciences and 2 mentions for Glass House Brands. IDEAYA Biosciences' average media sentiment score of 0.54 beat Glass House Brands' score of 0.00 indicating that IDEAYA Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Glass House Brands	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
IDEAYA Biosciences	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

IDEAYA Biosciences beats Glass House Brands on 8 of the 12 factors compared between the two stocks.

Get Glass House Brands News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GLAS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GLAS vs. The Competition

Export

Metric	Glass House Brands	Medicinal Chemicals Industry	Manufacturing Sector	NYSE Exchange
Market Cap	$848.48M	$1.36B	$4.43B	$23.52B
Dividend Yield	N/A	N/A	40.17%	4.17%
P/E Ratio	N/A	N/A	23.68	30.90
Price / Sales	4.82	2.10	133.49	173.98
Price / Cash	N/A	0.27	163.97	31.37
Price / Book	N/A	294.03	13.13	4.75
Net Income	N/A	-$1.41M	$120.21M	$1.07B
7 Day Performance	-3.39%	4.68%	-0.84%	-0.05%
1 Month Performance	N/A	-24.12%	-2.22%	1.54%
1 Year Performance	N/A	-56.99%	10.68%	16.32%

Glass House Brands Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GLAS Glass House Brands	N/A	$10.56 -1.5%	$17.00 +60.9%	N/A	$848.48M	$176.02M	N/A	N/A
ALMS Alumis	3.4405 of 5 stars	$28.81 +5.6%	$40.30 +39.9%	+805.1%	$3.48B	$8.40M	N/A	N/A	Positive News
ADPT Adaptive Biotechnologies	1.8599 of 5 stars	$22.90 +6.9%	$20.83 -9.0%	+119.0%	$3.43B	$276.98M	N/A	790	News Coverage Positive News Upcoming Earnings
ARQT Arcutis Biotherapeutics	3.2916 of 5 stars	$27.78 +3.6%	$34.00 +22.4%	+97.1%	$3.35B	$415.62M	N/A	150
GMTX Gemini Therapeutics	N/A	$75.01 -1.3%	N/A	+28.8%	$3.25B	N/A	N/A	30

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:GLAS) was last updated on 7/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Glass House Brands (GLAS) Competitors

GLAS vs. ALMS, ADPT, ARQT, GMTX, and IDYA

How does Glass House Brands compare to Alumis?

Summary

How does Glass House Brands compare to Adaptive Biotechnologies?

Summary

How does Glass House Brands compare to Arcutis Biotherapeutics?

Summary

How does Glass House Brands compare to Gemini Therapeutics?

Summary

How does Glass House Brands compare to IDEAYA Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GLAS vs. The Competition

Glass House Brands Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Glass House Brands (GLAS) Competitors

GLAS vs. ALMS, ADPT, ARQT, GMTX, and IDYA

How does Glass House Brands compare to Alumis?

Is GLAS or ALMS more profitable?

Which has better earnings & valuation, GLAS or ALMS?

Do analysts rate GLAS or ALMS?

Does the media favor GLAS or ALMS?

Summary

How does Glass House Brands compare to Adaptive Biotechnologies?

Does the media refer more to ADPT or GLAS?

Do analysts prefer ADPT or GLAS?

Is ADPT or GLAS more profitable?

Do insiders and institutionals believe in ADPT or GLAS?

Which has better earnings and valuation, ADPT or GLAS?

Summary

How does Glass House Brands compare to Arcutis Biotherapeutics?

Is GLAS or ARQT more profitable?

Does the media refer more to GLAS or ARQT?

Which has better earnings & valuation, GLAS or ARQT?

Do analysts rate GLAS or ARQT?

Summary

How does Glass House Brands compare to Gemini Therapeutics?

Do institutionals and insiders have more ownership in GLAS or GMTX?

Do analysts prefer GLAS or GMTX?

Is GLAS or GMTX more profitable?

Which has better earnings & valuation, GLAS or GMTX?

Does the media favor GLAS or GMTX?

Summary

How does Glass House Brands compare to IDEAYA Biosciences?

Do analysts prefer GLAS or IDYA?

Which has higher valuation & earnings, GLAS or IDYA?

Do institutionals & insiders have more ownership in GLAS or IDYA?

Is GLAS or IDYA more profitable?

Does the media favor GLAS or IDYA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GLAS vs. The Competition

Glass House Brands Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools